Larvol Delta - Biomea-Fusion-Presents-Data-Demonstrating-Enhanced-Preclinical-Activity-of-Icovamenib-in-Combination-with-Semaglutide-in-Type-2-Diabetes-T2D-Animal-Model-at-the-61st-EASD-Annual-Meeting

icovamenib (BMF-219) - Biomea Fusion

https://www.globenewswire.com/news-release/2025/09/16/3150644/0/en/Biomea-Fusion-Presents-Data-Demonstrating-Enhanced-Preclinical-Activity-of-Icovamenib-in-Combination-with-Semaglutide-in-Type-2-Diabetes-T2D-Animal-Model-at-the-61st-EASD-Annual-Me.html

Sep 16, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next